Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:17240151rdf:typepubmed:Citationlld:pubmed
pubmed-article:17240151lifeskim:mentionsumls-concept:C0025286lld:lifeskim
pubmed-article:17240151lifeskim:mentionsumls-concept:C0174680lld:lifeskim
pubmed-article:17240151lifeskim:mentionsumls-concept:C0017262lld:lifeskim
pubmed-article:17240151lifeskim:mentionsumls-concept:C0237881lld:lifeskim
pubmed-article:17240151lifeskim:mentionsumls-concept:C2603343lld:lifeskim
pubmed-article:17240151lifeskim:mentionsumls-concept:C0750502lld:lifeskim
pubmed-article:17240151lifeskim:mentionsumls-concept:C0439611lld:lifeskim
pubmed-article:17240151lifeskim:mentionsumls-concept:C2911684lld:lifeskim
pubmed-article:17240151lifeskim:mentionsumls-concept:C0185117lld:lifeskim
pubmed-article:17240151pubmed:issue4lld:pubmed
pubmed-article:17240151pubmed:dateCreated2007-3-5lld:pubmed
pubmed-article:17240151pubmed:abstractTextForty-four evaluable patients with intracranial meningiomas were assessed for the expression of the cell-cycle regulator cyclin D1 and of proteins involved in proliferation and apoptosis such as PCNA, MIB-1, p53 and bcl-2. Analyses were carried out by western blot and immunohistochemistry after immediate processing of fresh tumor specimens. By western blot, expression of cyclin D1 significantly correlated with p53 (p=0.02) and with proliferative activity, as assessed by PCNA expression (p=0.0009). By immunohistochemistry, a significant relationship between cyclin D1 and the proliferation marker MIB-1 was confirmed (p=0.05), whereas significance with bcl-2 expression was not found (p=0.01). Moreover, although the association with tumor grade appeared of borderline statistical significance (p=0.07), all the grade II/III meningiomas showed increased expression of cyclin D1 and high proliferative activity. In conclusion, data from this preliminary study seem to suggest a potential value of the combined expression of cyclin D1 and proliferation indicators in defining subgroups of meningiomas with a more aggressive biological behavior.lld:pubmed
pubmed-article:17240151pubmed:languageenglld:pubmed
pubmed-article:17240151pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17240151pubmed:citationSubsetIMlld:pubmed
pubmed-article:17240151pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17240151pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17240151pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17240151pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17240151pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17240151pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17240151pubmed:statusMEDLINElld:pubmed
pubmed-article:17240151pubmed:monthAprlld:pubmed
pubmed-article:17240151pubmed:issn0967-5868lld:pubmed
pubmed-article:17240151pubmed:authorpubmed-author:DorcarattoAle...lld:pubmed
pubmed-article:17240151pubmed:authorpubmed-author:BarbieriFeder...lld:pubmed
pubmed-article:17240151pubmed:authorpubmed-author:BruzzoCristin...lld:pubmed
pubmed-article:17240151pubmed:authorpubmed-author:AlamaAngelaAlld:pubmed
pubmed-article:17240151pubmed:authorpubmed-author:SpazianteRena...lld:pubmed
pubmed-article:17240151pubmed:authorpubmed-author:RavettiJean...lld:pubmed
pubmed-article:17240151pubmed:authorpubmed-author:DadatiPatrizi...lld:pubmed
pubmed-article:17240151pubmed:issnTypePrintlld:pubmed
pubmed-article:17240151pubmed:volume14lld:pubmed
pubmed-article:17240151pubmed:ownerNLMlld:pubmed
pubmed-article:17240151pubmed:authorsCompleteYlld:pubmed
pubmed-article:17240151pubmed:pagination355-8lld:pubmed
pubmed-article:17240151pubmed:meshHeadingpubmed-meshheading:17240151...lld:pubmed
pubmed-article:17240151pubmed:meshHeadingpubmed-meshheading:17240151...lld:pubmed
pubmed-article:17240151pubmed:meshHeadingpubmed-meshheading:17240151...lld:pubmed
pubmed-article:17240151pubmed:meshHeadingpubmed-meshheading:17240151...lld:pubmed
pubmed-article:17240151pubmed:meshHeadingpubmed-meshheading:17240151...lld:pubmed
pubmed-article:17240151pubmed:meshHeadingpubmed-meshheading:17240151...lld:pubmed
pubmed-article:17240151pubmed:meshHeadingpubmed-meshheading:17240151...lld:pubmed
pubmed-article:17240151pubmed:meshHeadingpubmed-meshheading:17240151...lld:pubmed
pubmed-article:17240151pubmed:meshHeadingpubmed-meshheading:17240151...lld:pubmed
pubmed-article:17240151pubmed:meshHeadingpubmed-meshheading:17240151...lld:pubmed
pubmed-article:17240151pubmed:meshHeadingpubmed-meshheading:17240151...lld:pubmed
pubmed-article:17240151pubmed:meshHeadingpubmed-meshheading:17240151...lld:pubmed
pubmed-article:17240151pubmed:meshHeadingpubmed-meshheading:17240151...lld:pubmed
pubmed-article:17240151pubmed:meshHeadingpubmed-meshheading:17240151...lld:pubmed
pubmed-article:17240151pubmed:meshHeadingpubmed-meshheading:17240151...lld:pubmed
pubmed-article:17240151pubmed:meshHeadingpubmed-meshheading:17240151...lld:pubmed
pubmed-article:17240151pubmed:meshHeadingpubmed-meshheading:17240151...lld:pubmed
pubmed-article:17240151pubmed:meshHeadingpubmed-meshheading:17240151...lld:pubmed
pubmed-article:17240151pubmed:meshHeadingpubmed-meshheading:17240151...lld:pubmed
pubmed-article:17240151pubmed:year2007lld:pubmed
pubmed-article:17240151pubmed:articleTitleSignificance of cyclin D1 expression in meningiomas: a preliminary study.lld:pubmed
pubmed-article:17240151pubmed:affiliationExperimental Pharmacology, National Institute for Cancer Research, Largo Rosanna Benzi, 10, 16132 Genova, Italy. angela.alama@istge.itlld:pubmed
pubmed-article:17240151pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:17240151pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
entrez-gene:595entrezgene:pubmedpubmed-article:17240151lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:17240151lld:entrezgene
lhgdn:association:21993lhgdn:found_inpubmed-article:17240151lld:lhgdn
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17240151lld:pubmed